Survival and clinical outcomes of salvage surgery in recurrent oral cavity cancer: a single institutional experience

Authors

  • Akansha A. Kandoi Department of Head and Neck Surgical Oncology, Kailash Cancer Hospital and Research Centre, Muni Seva Ashram, Goraj, Gujarat, India
  • Rajesh A. Kantharia Department of Head and Neck Surgical Oncology, Kailash Cancer Hospital and Research Centre, Muni Seva Ashram, Goraj, Gujarat, India
  • Shehnaz R. Kantharia Department of Otorhinolaryngology, Head and Neck Surgery, Kailash Cancer Hospital and Research Centre, Muni Seva Ashram, Goraj, Gujarat, India
  • Zahoor Ahmad Teli Department of Head and Neck Surgical Oncology, Kailash Cancer Hospital and Research Centre, Muni Seva Ashram, Goraj, Gujarat, India

DOI:

https://doi.org/10.18203/issn.2454-5929.ijohns20240700

Keywords:

Salvage Surgery, Recurrent oral cancer, Survival outcomes

Abstract

Background: Oral cavity is the most common site of head and neck squamous cell carcinoma in India with more than 70% presenting in locally advanced stage. Recurrence in all stages of OCSCC occurs in up to 50% of patients, with most failures being local and/or regional relapses. The present study was done to analyze clinical outcomes of patients undergoing salvage surgery (SS) following recurrent OCSCC.

Methods: A retrospective analysis of prospectively collected data of 82 patients with recurrent OCSCC was done in the department of head and neck surgery.

Results: At the end of 1 year post SS for OCSCC 62 out of 82 (75.6%) patients were alive without disease. At the end of 2 year after SS 22 out of 45 patients were alive of which 21 were alive without disease and 1 was alive with disease (48.8%). At the end of 3 years, 10 out of 25 of which 9 were alive without disease and 1 patient was alive with disease (40%). Median disease-free survival (DFS) post SS was 13.50 months (0-47 months). DFS and overall survival (OS) post SS showed significantly better results in patients treated with surgery along with RT as primary treatment, patients with late recurrence, patients with early recurrent T stage, patients with free margins at SS and in patients who received adjuvant radiation therapy post SS.

Conclusions: Salvage Surgery is one of the best treatment options for recurrent OCSCC with acceptable survival rates.

References

IARC Inc. India Fact Sheet 2020. 2020;361:2.

Parikh P, Patil V, Agarwal JP, Chaturvedi P, Vaidya A, Rathod S, et al. Guidelines for treatment of recurrent or metastatic head and neck cancer. Indian J Cancer. 2014;51(2):89-94.

Tam S, Araslanova R, Low TH, Warner A, Yoo J, Fung K, et al. Estimating survival after salvage surgery for recurrent oral cavity cancer. JAMA Otolaryngol Head Neck Surg. 2017;143(7):685-90.

González-García R. The role of salvage surgery in oral squamous cell carcinoma. Plast Aesthetic Res. 2016;3(6):189.

Lin YC, Hsiao JR, Tsai ST. Salvage surgery as the primary treatment for recurrent oral squamous cell carcinoma. Oral Oncol. 2004;40(2):183-9.

Brown JS, Blackburn TK, Woolgar JA, Lowe D, Errington RD, Vaughan ED, et al. A comparison of outcomes for patients with oral squamous cell carcinoma at intermediate risk of recurrence treated by surgery alone or with post-operative radiotherapy. Oral Oncol. 2007;43(8):764-73.

Chung EJ, Park MW, Kwon KH, Rho YS. Clinical outcomes and prognostic factor analysis after salvage surgery for recurrent squamous cell carcinoma of the oral cavity. Int J Oral Maxillofac Surg. 2020;49(3):285-91.

Kernohan MD, Clark JR, Gao K, Ebrahimi A, Milross CG. Predicting the prognosis of oral squamous cell carcinoma after first recurrence. Arch Otolaryngol Head Neck Surg. 2010;136(12):1235-9.

Liao CT, Chang JTC, Wang HM, Ng SH, Hsueh C, Lee LY, et al. Salvage therapy in relapsed squamous cell carcinoma of the oral cavity: How and when? Cancer. 2008;112(1):94-103.

Stell PM. Time to recurrence of squamous cell carcinoma of the head and neck. Head Neck. 1991;13(4):277-81.

Agra IM, João GF, Everton PM, Luiz PK. Second salvage surgery for re-recurrent oral cavity and oropharynx carcinoma. Head Neck. 2010;32(8):997-1002.

Matsuura D, Valim TD, Kulcsar MAV, Pinto FR, Brandão LG, Cernea CR, et al. Risk factors for salvage surgery failure in oral cavity squamous cell carcinoma. Laryngoscope. 2018;128(5):1113-9.

Haque S, Karivedu V, Riaz MK, Choi D, Roof L, Hassan SZ, et al. High-risk pathological features at the time of salvage surgery predict poor survival after definitive therapy in patients with head and neck squamous cell carcinoma. Oral Oncol. 2019;88:9-15.

Chang JH, Wu CC, Yuan KSP, Wu ATH, Wu SY. Locoregionally recurrent head and neck squamous cell carcinoma: Incidence, survival, prognostic factors, and treatment outcomes. Oncotarget. 2017;8(33):55600-12.

Koo BS, Lim YC, Lee JS, Choi EC. Recurrence and salvage treatment of squamous cell carcinoma of the oral cavity. Oral Oncol. 2006;42(8):789-94.

Suh JD, Kim BP, Abemayor E, Sercarz JA, Nabili V, Liu JH, et al. Reirradiation after salvage surgery and microvascular free flap reconstruction for recurrent head and neck carcinoma. Otolaryngol Head Neck Surg. 2008;139(6):781-6.

Kwon D, Genden EM, De Bree R, Rodrigo JP, Rinaldo A, Sanabria A, et al. Overcoming wound complications in head and neck salvage surgery. Auris Nasus Larynx. 2018;45(6):1135-42.

Downloads

Published

2024-03-26

Issue

Section

Original Research Articles